NCT07473583

Brief Summary

The goal of this observational study is to learn how the length of pneumoperitoneum during laparoscopic inguinal hernia surgery may affect changes in blood bicarbonate levels. Pneumoperitoneum is the use of carbon dioxide gas to create space inside the abdomen during laparoscopic surgery. The main question this study aims to answer is whether a longer pneumoperitoneum time is associated with changes in blood bicarbonate levels after surgery. Participants are adults undergoing laparoscopic inguinal hernia repair as part of their routine medical care. Researchers will measure blood gas values, including bicarbonate levels, before surgery and again two hours after surgery. The change in bicarbonate levels will be compared with the duration of pneumoperitoneum during the operation. The results of this study may help improve the understanding of metabolic changes that occur during laparoscopic surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

March 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

22 days

First QC Date

March 6, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

PneumoperitoneumLaparoscopic Inguinal Hernia RepairSerum BicarbonateBlood Gas AnalysisTAPP Technique

Outcome Measures

Primary Outcomes (1)

  • Change in Serum Bicarbonate Level

    Difference between preoperative and postoperative second-hour serum bicarbonate levels measured by blood gas analysis in patients undergoing laparoscopic inguinal hernia repair. Unit of Measure: mmol/L

    Preoperative to postoperative 2 hours

Secondary Outcomes (4)

  • Postoperative Pain Score

    Within 24 hours after surgery

  • Change in Arterial Blood pH

    Preoperative to postoperative 2 hours

  • Early Postoperative Complications

    Within 24 hours

  • Change in Arterial Partial Pressure of Carbon Dioxide

    Preoperative to postoperative 2 hours

Study Arms (1)

Laparoscopic Inguinal Hernia Patients

Adult patients undergoing laparoscopic inguinal hernia repair (TAPP). Pneumoperitoneum duration and perioperative serum bicarbonate changes will be analyzed using blood gas measurements obtained preoperatively and at the second postoperative hour.

Procedure: Laparoscopic Inguinal Hernia Repair (TAPP)

Interventions

Standard laparoscopic inguinal hernia repair performed using the transabdominal preperitoneal (TAPP) technique as part of routine clinical care. Pneumoperitoneum duration during the procedure will be recorded for analysis.

Laparoscopic Inguinal Hernia Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing laparoscopic inguinal hernia repair (TAPP) at Haseki Training and Research Hospital will be included. Perioperative pneumoperitoneum duration and serum bicarbonate changes will be analyzed using blood gas measurements obtained preoperatively and at the second postoperative hour.

You may qualify if:

  • Age ≥18 years
  • Patients undergoing laparoscopic inguinal hernia repair using the TAPP technique
  • Ability to provide informed consent

You may not qualify if:

  • Pregnancy
  • Severe cardiovascular disease
  • Renal insufficiency
  • Patients requiring additional intra-abdominal surgical procedures
  • Strangulated inguinal hernia requiring bowel resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haseki Training and Research Hospital

Istanbul, 34265, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Hernia, InguinalPneumoperitoneum

Interventions

tetra-4-amidinophenoxypropane

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPeritoneal DiseasesDigestive System Diseases

Study Officials

  • Muzaffer Akinci, MD

    Haseki Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bahar Canbay Torun, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2026

First Posted

March 16, 2026

Study Start

March 10, 2026

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to institutional data protection policies and patient confidentiality requirements. Only aggregated and anonymized data will be reported in scientific publications.

Locations